Fortis Advisors, LLC Novartis Ag Transaction History

Fortis Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $46,260 - $52,455	-500 Reduced 50.0%	500 $50,000
Q3 2021 Nov 23, 2021	SELL	$81.78 - $95.14 $347,810 - $404,630	-4,253 Reduced 80.96%	1,000 $82,000
Q3 2021 Nov 12, 2021	BUY	$81.78 - $95.14 $347,810 - $404,630	4,253 Added 425.3%	5,253 $86,000
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $164,280 - $182,000	-2,000 Reduced 66.67%	1,000 $87,000
Q2 2020 Aug 13, 2020	SELL	$80.93 - $91.1 $8,902 - $10,021	-110 Reduced 3.54%	3,000 $262,000
Q3 2019 Nov 14, 2019	BUY	$85.54 - $94.26 $9,409 - $10,368	110 Added 3.67%	3,110 $270,000
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $222,420 - $231,810	3,000	3,000 $258,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Fortis Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fortis Advisors, LLC with notifications on news.